Clinical trial preparations for the next pandemic

Research output: Contribution to journalArticlepeer-review


This paper describes the need to prepare for the development of antiviral therapeutics for the next pandemic. Preparation would consist of a stockpiling of best practices for clinical trial design, analysis and operations during the current SARS-CoV-2 pandemic as well as continuous development of treatments and methodology between pandemics. This development would be facilitated by a global clinical trial pandemic reserve similar to the military reserves consisting of medical and quantitative methods professionals who would remain engaged between pandemics. Continuous identification of potential antiviral drugs and diagnostic methods would also be needed. Specific methodology addressed includes the importance of large simple trials, follow up time, efficacy endpoint, appropriate estimands, non-inferiority trials, more sophisticated patient accrual models and procedures for data sharing between clinical trials.

Original languageEnglish (US)
Article number106292
JournalContemporary Clinical Trials
StatePublished - Mar 2021


  • COVID-19
  • Centralized statistical monitoring
  • Drug development
  • Estimands
  • Large simple trials

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'Clinical trial preparations for the next pandemic'. Together they form a unique fingerprint.

Cite this